| Literature DB >> 28203790 |
Sophia David1,2, Baharak Afshar2,3, Massimo Mentasti2, Christophe Ginevra4,5, Isabelle Podglajen6, Simon R Harris1, Victoria J Chalker2, Sophie Jarraud4,5, Timothy G Harrison2, Julian Parkhill1.
Abstract
Background: Legionnaires' disease is an important cause of hospital-acquired pneumonia and is caused by infection with the bacterium Legionella. Because current typing methods often fail to resolve the infection source in possible nosocomial cases, we aimed to determine whether whole-genome sequencing (WGS) could be used to support or refute suspected links between cases and hospitals. We focused on cases involving a major nosocomial-associated strain, L. pneumophila sequence type (ST) 1.Entities:
Keywords: Legionella pneumophila; Legionnaires’ disease; bacterial genomics; whole-genome sequencing; nosocomial infections
Mesh:
Year: 2017 PMID: 28203790 PMCID: PMC5399934 DOI: 10.1093/cid/cix153
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 20.999
Figure 1.A maximum likelihood tree of 229 sequence type (ST) 1 and ST1-derived isolates constructed using 1741 single-nucleotide polymorphisms (SNPs) identified after the removal of recombined regions. Environmental isolates from and clinical isolates linked to 27 different hospitals are included. Isolates from or potentially linked to the water systems of 10 of these hospitals (from which at least 1 environmental isolate and 1 clinical isolate was obtained) are colored within the tree itself. Clinical isolates from 28 suspected cases linked to these 10 hospitals are indicated by small circles (colored according to the hospital) and numbered within the tree. Clinical isolates obtained from the same patient have the same number. Bootstrap values obtained for nodes from which isolates from the 10 hospitals are descended are shown in red. The broken branches have been reduced to a third of their original size. The scale shows the number of SNPs. Abbreviations: mAb, monoclonal antibody; NA, not applicable; OLDA, ;SNP, single-nucleotide polymorphism; USA, United States.
Genomic Evidence to Support 28 Suspected Links Between Hospital Water Systems and Legionnaires’ Disease Cases, From Which at Least 1 Hospital Isolate and 1 Clinical Isolate Was Obtained and Analyzed Using Whole-Genome Sequencing
| Suspected Hospital | Date of Incident | Known Exposures During the Incubation Period (~18 d Prior to Onset of Symptoms) | Clinical Isolate(s) | Does the Clinical Isolate Cluster Most Closely With a Hospital Water Isolate? (No. of SNPs)a | Genomic Evidenceb |
|---|---|---|---|---|---|
| Hospital A, Essex, UK | May 2007 | Hospital A (11–18 d), home | H072360604 (case 1) | Yes (4 SNPs) | A |
| May 2007 | Hospital A (~12 d) | H072360603 (case 2) | Yes (3 SNPs) | A | |
| December 2009 | Hospital A (~4 d), home and local area | H100120270 (case 3) | Yes (1 SNP) | A | |
| December 2009 | Hospital A (~7 d), home and local area | H100120260 (case 4) | Yes (0 SNPs) | A | |
| November 2010 | Hospital A (~7 d), home and local area | H104720329 (case 5) | Yes (0 SNPs) | A | |
| August 2011 | Hospital A (at least 10 d) | H113580549, H113580550 (case 6) | Yes (3 and 0 SNPs, respectively) | A | |
| November 2011 | Hospital A (at least 10 d) | H114820438 (case 7) | Yes (0 SNPs) | A | |
| Hospital B, Wesley Hospital, Queensland, Australia | October 2011 | Hospital B | LP44 (case 8) | Yes (1 SNP) | A |
| May 2013 | Hospital B only | LP45, LP46 (case 9) | Yes (both 1 SNP) | A | |
| June 2013 | Hospital B only | LP47 and LP48 (case 10) | Yes (1 and 2 SNPs, respectively) | A | |
| Hospital C, Paris, France | March 2002 | Hospital C (13 d) and another hospital near Paris (5 d) | Paris (case 11) | Yes (2 SNPs different to isolate from hospital C). No isolates obtained from the other hospital | C (acquisition from other hospital cannot be excluded) |
| December 2000 | Hospital C only | HL 0051 1015 (case 12) | Yes (0 SNPs) | C | |
| December 2000 | Hospital C (~17 d) | HL 0051 4008 (case 13) | Yes (4 SNPs) | C | |
| December 2000 | Hospital C (~12 d) | HL 0101 3003 (case 14) | Yes (1 SNP) | C | |
| December 2000 | Hospital C (~4 d), home | HL 0102 3034 (case 15) | Yes (2 SNPs) | C | |
| December 2000 | Hospital C (~4 d), home | HL 0102 3035 (case 16) | Yes (2 SNPs) | C | |
| March 2007 | Hospital C only | LG 0713 5006 (case 17) | Yes (3 SNPs) | A | |
| Hospital D, near Marseille, France | April 2009 | Hospital D (~4 d), home | LG 0918 2002 (case 18) | Yes (0 SNPs) | C |
| April 2014 | Hospital D (~3 d), home (~3 d) | LG 1416 4007 (case 19) | Yes (1 SNP) | A | |
| April 2014 | Hospital D (~5 d) | LG 1416 4008 (case 20) | Yes (1 SNP) | A | |
| Hospital E, London, UK | June 2010 | Hospital E (at least 10 d) | H103120165 (case 21) | Yes (7 SNPs) | B |
| October 2012 | Hospital E (<10 d) | H124240908 (case 22) | Yes (33 SNPs) | B | |
| Hospital G, Cambridgeshire, UK | April 2010 | Hospital G (<10 d) | H101460286 (case 23) | Yes (2 SNPs) | D |
| Hospital H, London, UK | June 2009 | Hospital H (at least 10 d) | H092520167 (case 24) | Yes (1 SNP) | D |
| Hospital L, Cáceres Province, Spain | April 1994 | Hospital L | EUL 55 (case 25) | Yes (0 SNPs) | D |
| Hospital M, Copenhagen, Denmark | October 1992 | Hospital M only | EUL 93 (case 26) | Yes (0 SNPs) | D |
| December 1992 | Hospital M only | EUL 94 (case 27) | Yes (1 SNP) | D | |
| Hospital N, near Marseille, France | April 2010 | Hospital N only | LG 1019 1002 (case 28) | Yes (1 SNP) | D |
Abbreviation: SNP, single-nucleotide polymorphism.
aSNP differences refer to those that remain after the removal of recombined regions.
bDifferent types of genomic evidence were categorized. A: The clinical isolate(s) is derived from the most recent common ancestor (MRCA) of the hospital isolates, and differs by <5 SNPs to the closest hospital water isolate. Strong evidence that the infection was hospital-acquired. B: The clinical isolate(s) is derived from the MRCA of the hospital isolates, but differs by >5 SNPs to the closest hospital water isolate. Good evidence that the infection was hospital-acquired. C: The clinical isolate(s) clusters most closely with hospital isolates, and is <5 SNPs different from the closest hospital isolate. However, the clinical isolate(s) is not derived from the MRCA of the sampled hospital isolates. Acquisition from elsewhere cannot be excluded on the basis of genomic evidence alone. D: The clinical isolate(s) clusters most closely to and differs by <5 SNPs from the hospital isolate. However, the recovery of only 1 hospital isolate prevents the determination of whether the clinical isolate is derived from hospital isolates. Acquisition from elsewhere cannot be excluded on the basis of genomic evidence alone.
Figure 2.A, The time frame in which 10 cases of Legionnaires’ disease that are considered to have been acquired in hospital A occurred between the end of 2006 and 2011 (bottom panel). Clinical isolates were obtained from 7 of these cases, as indicated. Environmental isolates were also obtained between 2007 and 2012 from the hospital water supply, usually after each Legionnaires’ disease incident (top panel). Isolates are colored according to the hospital ward(s) in which the patient stayed (clinical isolates) or they were sampled (environmental isolates). B, A plan of hospital A, showing the wards in which the patients stayed, and those in which the environmental isolates were obtained. C, A zoomed-in section of the maximum likelihood tree presented in Figure 1, showing environmental isolates from and clinical isolates linked to hospital A. Clinical isolates from 7 cases linked to hospital A are indicated by small circles and numbered 1–7 (2 isolates were obtained from case 6). Closely related isolates sampled from nearby homes are also shown, including the home of a patient (case 3) who spent part of their incubation period in hospital A as well as 3 homes of patients who had no known epidemiological link to hospital A. Clinical isolates from these latter 3 patients are indicated by small circles and labeled A–C. Clinical isolate A was obtained from a patient whose incubation period was spent both at home and in hospital F, while isolates B and C are from patients with no known epidemiological links to any hospitals. Bootstrap values for all nodes in the tree are provided in Supplementary Figure 1. Abbreviations: LD, Legionnaires’ disease; mAb, monoclonal antibody; NA, not applicable; SNP, single-nucleotide polymorphism.
Figure 3.A–D, Zoomed-in sections of the maximum likelihood tree presented in Figure 1. All clinical isolates are indicated by small circles, with those from the 28 cases under investigation colored and numbered as in Figure 1. Where applicable, isolates are additionally colored in the right-hand panel according to the hospital ward(s) in which the patient stayed (clinical isolates) or they were sampled (environmental isolates). Clinical isolates from the 28 cases under investigation are also colored in the right-hand panel by the strength of genomic evidence for hospital acquisition (see Table 1). Abbreviations: mAb, monoclonal antibody; NA, not applicable; SNP, single-nucleotide polymorphism.